DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Onyx Biotec Limited — Corrigendum

NSE 2 hrs ago·4 Aug 2026, 5:25 am

Onyx Biotec

Onyx Biotec has submitted a corrigendum to a public announcement made on July 24, 2026. This document corrects or clarifies information previously disclosed to public shareholders. The update was filed by VC Corporate Advisors, who manage the process for the company.

This development is a routine administrative step and does not indicate a change in the company's fundamental business or financial position. It is primarily intended to ensure that all shareholders have access to accurate and consistent information regarding the company's affairs.

Investors should review the corrigendum to understand the specific details of the correction. There are no immediate market-moving implications, but keeping an eye on the company's future disclosures remains important.